Sign in

CIK 0001347178

  • Accelerated filer

Vanda Pharmaceuticals Inc.

Sign in to watch
Ticker
VNDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
030491827
Phone
+1 202-734-3400
Business address
2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
Open-market buys, last 90 days
$38,094
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$38,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Duncan Charles Cliff +$38K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2016-06-16 Watkins Thomas Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2016-06-16 MILANO VINCENT Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2016-06-16 DUGAN RICHARD W Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2016-06-16 COLA MICHAEL F Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2016-06-16 BATE KENNETH Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2016-02-12 Reverberi Gian Piero SVP, Acting CCO & GM Europe Grant or award · Employee Stock Option (Right to Buy) +70,000 70,000
2016-02-12 Reverberi Gian Piero SVP, Acting CCO & GM Europe Grant or award · Restricted Stock Unit +30,000 30,000
2016-02-12 Polymeropoulos Mihael Hristos President and CEO Grant or award · Employee Stock Option (Right to Buy) +175,000 175,000
2016-02-12 Polymeropoulos Mihael Hristos President and CEO Grant or award · Restricted Stock Unit +75,000 75,000
2016-02-12 Kelly James Patrick SVP, CFO, Sec & Treasurer Grant or award · Employee Stock Option (Right to Buy) +70,000 70,000
2016-02-12 Kelly James Patrick SVP, CFO, Sec & Treasurer Grant or award · Restricted Stock Unit +30,000 30,000
2016-02-12 Gulino Richard L. SVP & General Counsel Grant or award · Employee Stock Option (Right to Buy) +70,000 70,000
2016-02-12 Gulino Richard L. SVP & General Counsel Grant or award · Restricted Stock Unit +30,000 30,000
2016-02-12 Baroldi Paolo SVP & Chief Medical Officer Grant or award · Employee Stock Option (Right to Buy) +70,000 70,000
2016-02-12 Baroldi Paolo SVP & Chief Medical Officer Grant or award · Restricted Stock Unit +30,000 30,000
2016-01-04 Polymeropoulos Mihael Hristos President and CEO Exercise or conversion +12,500 829,281
2016-01-04 Polymeropoulos Mihael Hristos President and CEO Exercise or conversion +6,250 835,531
2016-01-04 Polymeropoulos Mihael Hristos President and CEO Exercise or conversion +12,500 848,031
2016-01-04 Polymeropoulos Mihael Hristos President and CEO Exercise or conversion +12,500 860,531
2016-01-04 Polymeropoulos Mihael Hristos President and CEO Sale −21,353 $8.96 $191K 839,178

Page 25 of 36 · 717 trades